{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:09:23Z","timestamp":1767913763631,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["SFB1286 (project A06)"],"award-info":[{"award-number":["SFB1286 (project A06)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Projekt DEAL"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Leber hereditary optic neuropathy (LHON) is the most common mitochondrial disorder and characterized by acute or subacute painless visual loss. Environmental factors reported to trigger visual loss in LHON mutation carriers include smoking, heavy intake of alcohol, raised intraocular pressure, and some drugs, including several carbonic anhydrase inhibitors. The antiepileptic drug sulthiame (STM) is effective especially in focal seizures, particularly in benign epilepsy of childhood with centrotemporal spikes, and widely used in pediatric epileptology. STM is a sulfonamide derivate and an inhibitor of mammalian carbonic anhydrase isoforms I\u2013XIV.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We describe two unrelated patients, an 8-year-old girl and an 11-year-old boy, with cryptogenic focal epilepsy, who suffered binocular (subject #1) or monocular (subject #2) visual loss in close temporal connection with starting antiepileptic pharmacotherapy with STM. In both subjects, visual loss was due to LHON. We used real-time respirometry in fibroblasts derived from LHON patients carrying the same mitochondrial mutations as our two subjects to investigate the effect of STM on oxidative phosphorylation. Oxygen consumption rate in fibroblasts from a healthy control was not impaired by STM compared with a vehicle control. In contrast, fibroblasts carrying the m.14484T&gt;C or the m.3460G&gt;A LHON mutation displayed a drastic reduction of the respiration rate when treated with STM compared to vehicle control.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our observations point to a causal relationship between STM treatment and onset or worsening of visual failure in two subjects with LHON rather than pure coincidence. We conclude that antiepileptic medication with STM may pose a risk for visual loss in LHON mutation carriers and should be avoided in these patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-021-01690-y","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T12:06:13Z","timestamp":1612440373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Sulthiame impairs mitochondrial function in vitro and may trigger onset of visual loss in Leber hereditary optic neuropathy"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8573-9888","authenticated-orcid":false,"given":"Marie-Christine","family":"Reinert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Pacheu-Grau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia B.","family":"Catarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Klopstock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Ohlenbusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schittkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekkehard","family":"Wilichowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Rehling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Knut","family":"Brockmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,4]]},"reference":[{"issue":"3","key":"1690_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/00007691-199406000-00005","volume":"16","author":"TW May","year":"1994","unstructured":"May TW, Korn-Merker E, Rambeck B, Boenigk HE. Pharmacokinetics of sulthiame in epileptic patients. Ther Drug Monit. 1994;16(3):251\u20137.","journal-title":"Ther Drug Monit"},{"issue":"10","key":"1690_CR2","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/j.1528-1157.2000.tb04606.x","volume":"41","author":"D Rating","year":"2000","unstructured":"Rating D, Wolf C, Bast T. Sulthiame as monotherapy in children with benign childhood epilepsy with centrotemporal spikes: a 6-month randomized, double-blind, placebo-controlled study. Sulthiame study group. Epilepsia. 2000;41(10):1284\u20138.","journal-title":"Epilepsia"},{"issue":"12","key":"1690_CR3","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1177\/08830738020170123004","volume":"17","author":"U Kramer","year":"2002","unstructured":"Kramer U, Shahar E, Zelnik N, Lerman-Sagie T, Watemberg N, Nevo Y, et al. Carbamazepine versus sulthiame in treating benign childhood epilepsy with centrotemporal spikes. J Child Neurol. 2002;17(12):914\u20136.","journal-title":"J Child Neurol"},{"key":"1690_CR4","first-page":"903","volume-title":"Pellock\u2019s pediatric epilepsy: diagnosis and therapy","author":"D Rating","year":"2016","unstructured":"Rating D, Wolf N, Bast T, Sulthiame RJ. Pellock\u2019s pediatric epilepsy: diagnosis and therapy. 4th ed. New York, NY: Demos Medical; 2016. p. 903\u201311.","edition":"4"},{"issue":"3","key":"1690_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1747-0285.2009.00857.x","volume":"74","author":"G De Simone","year":"2009","unstructured":"De Simone G, Scozzafava A, Supuran CT. Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates? Chem Biol Drug Des. 2009;74(3):317\u201321.","journal-title":"Chem Biol Drug Des"},{"key":"1690_CR6","volume-title":"Goodman & Gilman\u2019s pharmacological basis of therapeutics","year":"2011","unstructured":"Goodman LS, Brunton LL, Chabner B, Knollmann BC, editors. Goodman & Gilman\u2019s pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill; 2011.","edition":"12"},{"issue":"8","key":"1690_CR7","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1001\/archopht.1977.04450080088009","volume":"95","author":"DL Epstein","year":"1977","unstructured":"Epstein DL, Grant WM. Carbonic anhydrase inhibitor side effects. Serum chemical analysis. Arch Ophthalmol. 1977;95(8):1378\u201382.","journal-title":"Arch Ophthalmol"},{"issue":"7389","key":"1690_CR8","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/S0140-6736(65)92986-7","volume":"1","author":"A Aviram","year":"1965","unstructured":"Aviram A, Czaczkes JW, Rosenmann E. Acute renal failure associated with sulthiame. Lancet Lond Engl. 1965;1(7389):818.","journal-title":"Lancet Lond Engl"},{"issue":"12","key":"1690_CR9","first-page":"542","volume":"34","author":"U Tr\u00f6ger","year":"1996","unstructured":"Tr\u00f6ger U, Fritzsch C, Darius J, Gedschold J, Meyer FP. Sulthiame-associated mild compensated metabolic acidosis. Int J Clin Pharmacol Ther. 1996;34(12):542\u20135.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"1","key":"1690_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1055\/s-2007-973459","volume":"30","author":"J Weglage","year":"1999","unstructured":"Weglage J, Pietsch M, Sprinz A, Feldmann R, Denecke J, Kurlemann G. A previously unpublished side effect of sulthiame in a patient with Rolandic epilepsy. Neuropediatrics. 1999;30(1):50.","journal-title":"Neuropediatrics"},{"issue":"1","key":"1690_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/0883073807307082","volume":"23","author":"E Wirrell","year":"2008","unstructured":"Wirrell E, Sherman EMS, Vanmastrigt R, Hamiwka L. Deterioration in cognitive function in children with benign epilepsy of childhood with central temporal spikes treated with sulthiame. J Child Neurol. 2008;23(1):14\u201321.","journal-title":"J Child Neurol"},{"issue":"3","key":"1690_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1055\/s-2001-16617","volume":"32","author":"K Brockmann","year":"2001","unstructured":"Brockmann K, Hanefeld F. Progressive elevation of liver enzymes in a child treated with sulthiame. Neuropediatrics. 2001;32(3):165\u20136.","journal-title":"Neuropediatrics"},{"issue":"10","key":"1690_CR13","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/PEC.0b013e3181f39b4b","volume":"26","author":"A Weissbach","year":"2010","unstructured":"Weissbach A, Tirosh I, Scheuerman O, Hoffer V, Garty BZ. Respiratory alkalosis and metabolic acidosis in a child treated with sulthiame. Pediatr Emerg Care. 2010;26(10):752\u20133.","journal-title":"Pediatr Emerg Care"},{"issue":"3","key":"1690_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s100480100115","volume":"3","author":"K Huoponen","year":"2001","unstructured":"Huoponen K. Leber hereditary optic neuropathy: clinical and molecular genetic findings. Neurogenetics. 2001;3(3):119\u201325.","journal-title":"Neurogenetics"},{"key":"1690_CR15","unstructured":"Yu-Wai-Man P, Chinnery PF. Leber hereditary optic neuropathy. 2000 Oct 26 [updated 2016 Jun 23]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews\u00ae [Internet]. Seattle, WA: University of Washington, Seattle; 1993\u20132020. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1174\/. Accessed 17 Nov 2020."},{"issue":"Pt 9","key":"1690_CR16","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1093\/brain\/awr170","volume":"134","author":"T Klopstock","year":"2011","unstructured":"Klopstock T, Yu-Wai-Man P, Dimitriadis K, Rouleau J, Heck S, Bailie M, et al. A randomized placebo-controlled trial of idebenone in Leber\u2019s hereditary optic neuropathy. Brain J Neurol. 2011;134(Pt 9):2677\u201386.","journal-title":"Brain J Neurol"},{"issue":"2","key":"1690_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1086\/346066","volume":"72","author":"P Yu-Wai-Man","year":"2003","unstructured":"Yu-Wai-Man P, Griffiths PG, Brown DT, Howell N, Turnbull DM, Chinnery PF. The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am J Hum Genet. 2003;72(2):333\u20139.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"1690_CR18","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1136\/jmg.39.3.162","volume":"39","author":"P Yu-Wai-Man","year":"2002","unstructured":"Yu-Wai-Man P, Turnbull DM, Chinnery PF. Leber hereditary optic neuropathy. J Med Genet. 2002;39(3):162\u20139.","journal-title":"J Med Genet"},{"issue":"Pt 9","key":"1690_CR19","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1093\/brain\/awp158","volume":"132","author":"MA Kirkman","year":"2009","unstructured":"Kirkman MA, Yu-Wai-Man P, Korsten A, Leonhardt M, Dimitriadis K, De Coo IF, et al. Gene-environment interactions in Leber hereditary optic neuropathy. Brain J Neurol. 2009;132(Pt 9):2317\u201326.","journal-title":"Brain J Neurol"},{"issue":"5","key":"1690_CR20","doi-asserted-by":"publisher","first-page":"e63446","DOI":"10.1371\/journal.pone.0063446","volume":"8","author":"A Thouin","year":"2013","unstructured":"Thouin A, Griffiths PG, Hudson G, Chinnery PF, Yu-Wai-Man P. Raised intraocular pressure as a potential risk factor for visual loss in Leber Hereditary Optic Neuropathy. PLoS ONE. 2013;8(5):e63446.","journal-title":"PLoS ONE"},{"issue":"12","key":"1690_CR21","doi-asserted-by":"publisher","first-page":"e2021","DOI":"10.1038\/cddis.2015.364","volume":"6","author":"L Giordano","year":"2015","unstructured":"Giordano L, Deceglie S, d\u2019Adamo P, Valentino ML, La Morgia C, Fracasso F, et al. Cigarette toxicity triggers Leber\u2019s hereditary optic neuropathy by affecting mtDNA copy number, oxidative phosphorylation and ROS detoxification pathways. Cell Death Dis. 2015;6(12):e2021.","journal-title":"Cell Death Dis"},{"issue":"2","key":"1690_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1212\/WNL.50.2.417","volume":"50","author":"C Macmillan","year":"1998","unstructured":"Macmillan C, Kirkham T, Fu K, Allison V, Andermann E, Chitayat D, et al. Pedigree analysis of French Canadian families with T14484C Leber\u2019s hereditary optic neuropathy. Neurology. 1998;50(2):417\u201322.","journal-title":"Neurology"},{"issue":"2","key":"1690_CR23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/jnnp.59.2.160","volume":"59","author":"EK Nikoskelainen","year":"1995","unstructured":"Nikoskelainen EK, Marttila RJ, Huoponen K, Juvonen V, Lamminen T, Sonninen P, et al. Leber\u2019s \u2018plus\u2019: neurological abnormalities in patients with Leber\u2019s hereditary optic neuropathy. J Neurol Neurosurg Psychiatry. 1995;59(2):160\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"1690_CR24","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1167\/iovs.17-21990","volume":"58","author":"N Vestergaard","year":"2017","unstructured":"Vestergaard N, Rosenberg T, Torp-Pedersen C, Vorum H, Andersen CU, Aasbjerg K. Increased mortality and comorbidity associated with Leber\u2019s hereditary optic neuropathy: a nationwide cohort study. Invest Ophthalmol Vis Sci. 2017;58(11):4586\u201392.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1690_CR25","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.mito.2018.07.007","volume":"46","author":"K Kogachi","year":"2019","unstructured":"Kogachi K, Ter-Zakarian A, Asanad S, Sadun A, Karanjia R. Toxic medications in Leber\u2019s hereditary optic neuropathy. Mitochondrion. 2019;46:270\u20137.","journal-title":"Mitochondrion"},{"issue":"4","key":"1690_CR26","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/jimd.12196","volume":"43","author":"M De Vries","year":"2020","unstructured":"De Vries M, Brown D, Allen M, Bindoff L, Gorman G, et al. Safety of drug use in patients with a primary mitochondrial disease: an international Delphi-based consensus. J Inherit Metab Dis. 2020;43(4):800\u201318.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"1690_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/aos.12515","volume":"93","author":"A Grzybowski","year":"2015","unstructured":"Grzybowski A, Z\u00fclsdorff M, Wilhelm H, Tonagel F. Toxic optic neuropathies: an updated review. Acta Ophthalmol. 2015;93(5):402\u201310.","journal-title":"Acta Ophthalmol"},{"issue":"9","key":"1690_CR28","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1007\/s004150170103","volume":"248","author":"M De Marinis","year":"2001","unstructured":"De Marinis M. Optic neuropathy after treatment with anti-tuberculous drugs in a subject with Leber\u2019s hereditary optic neuropathy mutation. J Neurol. 2001;248(9):818\u20139.","journal-title":"J Neurol"},{"issue":"3","key":"1690_CR29","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s10384-005-0308-7","volume":"50","author":"A Ikeda","year":"2006","unstructured":"Ikeda A, Ikeda T, Ikeda N, Kawakami Y, Mimura O. Leber\u2019s hereditary optic neuropathy precipitated by ethambutol. Jpn J Ophthalmol. 2006;50(3):280\u20133.","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"1690_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3109\/08820538.2010.541320","volume":"26","author":"KS Cornish","year":"2011","unstructured":"Cornish KS, Barras C. Leber\u2019s hereditary optic neuropathy precipitated by tadalafil use for erectile dysfunction. Semin Ophthalmol. 2011;26(1):7\u201310.","journal-title":"Semin Ophthalmol"},{"issue":"2","key":"1690_CR31","first-page":"419","volume":"33","author":"S Rinalduzzi","year":"2012","unstructured":"Rinalduzzi S, Cipriani AM, Accornero N. Topiramate and visual loss in a patient carrying a Leber hereditary optic neuropathy mutation. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2012;33(2):419\u201321.","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"key":"1690_CR32","first-page":"339","volume":"2","author":"A Mukherjee","year":"1980","unstructured":"Mukherjee A, Wong TM, Buja LM, Willerson JT. Oxidative phosphorylation in isolated canine myocardial mitochondria. Effects of in vitro volume dilution, lactate, phosphate, and calcium addition, and lactic acidosis. Adv Myocardiol. 1980;2:339\u201347.","journal-title":"Adv Myocardiol"},{"issue":"3","key":"1690_CR33","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/jcbfm.1984.62","volume":"4","author":"L Hillered","year":"1984","unstructured":"Hillered L, Ernster L, Siesj\u00f6 BK. Influence of in vitro lactic acidosis and hypercapnia on respiratory activity of isolated rat brain mitochondria. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab. 1984;4(3):430\u20137.","journal-title":"J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab"},{"issue":"6 Pt 2","key":"1690_CR34","first-page":"H1818","volume":"262","author":"G Suleymanlar","year":"1992","unstructured":"Suleymanlar G, Zhou HZ, McCormack M, Elkins N, Kucera R, Reiss OK, et al. Mechanism of impaired energy metabolism during acidosis: role of oxidative metabolism. Am J Physiol. 1992;262(6 Pt 2):H1818-1822.","journal-title":"Am J Physiol"},{"issue":"1","key":"1690_CR35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00381-004-1130-0","volume":"22","author":"T Go","year":"2006","unstructured":"Go T. Effect of antiepileptic drug monotherapy on urinary pH in children and young adults. Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg. 2006;22(1):56\u20139.","journal-title":"Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg"},{"issue":"3","key":"1690_CR36","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ajhg.2014.01.006","volume":"94","author":"CD van Karnebeek","year":"2014","unstructured":"van Karnebeek CD, Sly WS, Ross CJ, Salvarinova R, Yaplito-Lee J, Santra S, et al. Mitochondrial carbonic anhydrase VA deficiency resulting from CA5A alterations presents with hyperammonemia in early childhood. Am J Hum Genet. 2014;94(3):453\u201361.","journal-title":"Am J Hum Genet"},{"issue":"7","key":"1690_CR37","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1016\/j.jmb.2020.01.036","volume":"432","author":"D Pacheu-Grau","year":"2020","unstructured":"Pacheu-Grau D, Wasilewski M, Oeljeklaus S, Gibhardt CS, Aich A, Chudenkova M, et al. COA6 facilitates cytochrome c oxidase biogenesis as thiol-reductase for copper metallochaperones in mitochondria. J Mol Biol. 2020;432(7):2067\u201379.","journal-title":"J Mol Biol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01690-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-021-01690-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01690-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T12:30:00Z","timestamp":1612441800000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-01690-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,4]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1690"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-01690-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,4]]},"assertion":[{"value":"2 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in accordance with the Declaration of Helsinki and was approved by the ethics committee of the Medical Faculty, Ludwig-Maximilian-University Munich, Munich, Germany.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details was obtained from the parents of the patient. A copy of the consent form is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}